Gsk GSK
NYSE GSK
$52.13 +0.17 (+0.33%)
As of: Aug 21, 2026 · 10:27 AM EDT

Gsk (GSK) Share-based Compensation (2009 - 2015)

Gsk (GSK) posted quarterly Share-based Compensation of $558.4 million for Q4 2015, up 6.16% year-over-year from $526.0 million in Q4 2014, and up 6.16% quarter-over-quarter from $526.0 million in Q4 2014.

Gsk (GSK) Share-based Compensation (2009 - 2015) Analysis & Trends

Gsk's Share-based Compensation history runs 7 years deep, the most recent figure standing at $558.4 million for Q4 2015.

  • In Q4 2015, Share-based Compensation rose 6.16% year-over-year to $558.4 million; the TTM figure through Dec 2015 stood at $2.0 billion (up 14.49% YoY), while the FY2018 annual figure was $480.8 million, up 12.08% from the prior year.
  • Share-based Compensation for Q4 2015 stood at $558.4 million, up from $526.0 million in the prior quarter.
  • The five-year high for Share-based Compensation was $558.4 million in Q4 2015, with the low at $311.2 million in Q4 2011.
  • The 5-year median for Share-based Compensation is $516.5 million (2013), against an average of $453.1 million.
  • The sharpest annual moves came in 2013 and 2014: Share-based Compensation jumped 46.19% in 2013, then increased 1.85% in 2014.
  • Gsk's Share-based Compensation stood at $311.2 million in 2011, then climbed by 13.54% to $353.3 million in 2012, then soared by 46.19% to $516.5 million in 2013, then climbed by 1.85% to $526.0 million in 2014, then increased by 6.16% to $558.4 million in 2015.
  • Business Quant data shows GSK's Share-based Compensation at $558.4 million in Q4 2015, $526.0 million in Q4 2014, and $516.5 million in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.97 Bn 635.21 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.01 Bn 463.44 Bn 12.70 Bn 166.00 Mn
3 Merck 380.54 Bn 373.40 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 302.93 Bn 295.24 Bn 11.24 Bn -
5 Astrazeneca 258.10 Bn 253.20 Bn 12.86 Bn -
6 Amgen 237.12 Bn 223.14 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 183.14 Bn 179.96 Bn 6.22 Bn 231.00 Mn
8 Pfizer 161.51 Bn 149.81 Bn 10.94 Bn 249.00 Mn
9 Gsk 105.87 Bn 101.71 Bn 8.24 Bn -
10 Sanofi 55.06 Bn 47.68 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 558.44 Mn
Dec 31, 2015 558.44 Mn
Dec 31, 2014 526.02 Mn
Dec 31, 2014 526.02 Mn
Dec 31, 2013 516.48 Mn
Dec 31, 2013 516.48 Mn
Dec 31, 2012 353.29 Mn
Dec 31, 2012 353.29 Mn
Dec 31, 2011 311.17 Mn
Dec 31, 2011 311.17 Mn
Dec 31, 2010 282.80 Mn
Dec 31, 2010 282.80 Mn
Dec 31, 2009 292.39 Mn
Dec 31, 2009 292.39 Mn